Free Trial

Clearfield (CLFD) Financials

Clearfield logo
$46.74 -4.52 (-8.81%)
As of 02:20 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Clearfield

Annual Income Statements for Clearfield

This table shows Clearfield's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Net Income / (Loss) Attributable to Common Shareholders
4.68 8.01 3.85 4.27 4.57 7.29 20 49 33 -12 2.36
Consolidated Net Income / (Loss)
4.68 8.01 3.85 4.27 4.57 7.29 20 49 33 -12 -8.05
Net Income / (Loss) Continuing Operations
4.68 8.01 3.85 4.27 4.57 7.29 20 49 34 -8.51 6.31
Total Pre-Tax Income
7.16 11 5.59 5.53 5.93 9.16 26 64 43 -12 8.67
Total Operating Income
7.05 11 5.31 5.07 5.19 8.38 25 64 38 -19 2.12
Total Gross Profit
25 33 30 31 33 38 61 113 80 26 51
Total Revenue
60 75 74 78 85 93 141 271 226 126 150
Operating Revenue
60 75 74 78 85 93 141 271 226 126 150
Total Cost of Revenue
35 42 44 47 52 55 80 158 146 100 100
Operating Cost of Revenue
35 42 44 47 52 55 80 158 146 100 100
Total Operating Expenses
18 22 25 26 28 30 36 49 42 45 48
Selling, General & Admin Expense
18 22 25 26 28 30 36 49 42 45 48
Total Other Income / (Expense), net
0.11 0.16 0.27 0.46 0.74 0.77 0.50 0.02 5.03 7.47 6.55
Interest & Investment Income
0.11 0.16 0.27 0.46 0.74 0.77 0.50 0.02 5.03 7.47 6.55
Income Tax Expense
2.48 2.88 1.74 1.25 1.36 1.86 5.41 14 8.88 -3.25 2.36
Net Income / (Loss) Discontinued Operations
- - - - - - - - -1.19 -3.94 -3.95
Basic Earnings per Share
$0.35 $0.60 $0.28 $0.32 $0.34 $0.53 $1.48 $3.58 $2.17 ($0.85) ($0.58)
Weighted Average Basic Shares Outstanding
13.22M 13.37M 13.53M 13.43M 13.44M 13.64M 13.72M 13.77M 14.98M 14.58M 13.99M
Diluted Earnings per Share
$0.34 $0.59 $0.28 $0.32 $0.34 $0.53 $1.47 $3.55 $2.17 ($0.85) ($0.58)
Weighted Average Diluted Shares Outstanding
13.59M 13.66M 13.66M 13.45M 13.45M 13.64M 13.78M 13.91M 15.01M 14.58M 13.99M
Weighted Average Basic & Diluted Shares Outstanding
13.40M 13.40M 13.70M 13.65M 13.64M 13.65M 13.73M 13.82M 15.25M 14.29M 13.84M

Quarterly Income Statements for Clearfield

This table shows Clearfield's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
2.70 -5.27 -5.91 -0.45 -0.83 -1.91 1.33 1.61 1.34 -0.61 -0.53
Consolidated Net Income / (Loss)
2.70 -5.27 -5.91 -0.45 -0.83 -1.91 1.33 1.61 -9.08 -0.61 -0.53
Net Income / (Loss) Continuing Operations
2.70 -5.27 -5.91 -0.45 -0.83 -0.36 2.55 1.61 5.28 -0.28 -0.53
Total Pre-Tax Income
3.26 -6.22 -7.99 -0.72 -1.32 -0.30 3.27 2.98 6.24 -0.28 -0.70
Total Operating Income
1.72 -8.16 -9.74 -2.31 -3.01 -2.05 1.68 1.50 4.34 -1.82 -2.07
Total Gross Profit
12 4.70 2.83 11 11 8.68 14 15 13 11 11
Total Revenue
50 34 37 49 47 30 41 50 18 34 34
Operating Revenue
50 34 37 49 47 30 41 50 18 34 34
Total Cost of Revenue
38 30 34 38 36 21 27 35 4.66 23 23
Operating Cost of Revenue
38 30 34 38 36 21 27 35 4.66 23 23
Total Operating Expenses
10 13 13 13 14 11 12 14 8.59 13 13
Selling, General & Admin Expense
10 13 13 13 14 11 12 14 8.59 13 13
Total Other Income / (Expense), net
1.55 1.94 1.75 1.58 1.69 1.74 1.59 1.48 1.90 1.55 1.37
Interest & Investment Income
1.55 1.94 1.75 1.58 1.69 1.74 1.59 1.48 1.90 1.55 1.37
Income Tax Expense
0.57 -0.95 -2.08 -0.28 -0.49 0.05 0.72 1.37 0.96 -0.00 -0.18
Net Income / (Loss) Discontinued Operations
- - - - - -1.55 -1.22 - - -0.34 0.00
Basic Earnings per Share
$0.16 ($0.35) ($0.40) ($0.04) ($0.06) ($0.13) $0.09 $0.11 ($0.65) ($0.04) ($0.04)
Weighted Average Basic Shares Outstanding
14.98M 15.21M 14.63M 14.25M 14.58M 14.21M 14.10M 13.83M 13.99M 13.87M 13.67M
Diluted Earnings per Share
$0.17 ($0.35) ($0.40) ($0.04) ($0.06) ($0.13) $0.09 $0.11 ($0.65) ($0.04) ($0.04)
Weighted Average Diluted Shares Outstanding
15.01M 15.21M 14.63M 14.25M 14.58M 14.21M 14.10M 13.83M 13.99M 13.87M 13.67M
Weighted Average Basic & Diluted Shares Outstanding
15.25M 14.71M 14.23M 14.24M 14.29M 14.13M 13.83M 13.81M 13.84M 13.69M 13.59M

Annual Cash Flow Statements for Clearfield

This table details how cash moves in and out of Clearfield's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Net Change in Cash & Equivalents
-0.12 9.94 -9.48 -9.99 1.53 6.37 -3.23 3.43 21 -22 1.64
Net Cash From Operating Activities
6.85 12 6.30 4.55 15 6.66 11 2.26 25 18 22
Net Cash From Continuing Operating Activities
6.85 12 6.30 4.55 15 6.66 11 2.26 25 18 27
Net Income / (Loss) Continuing Operations
4.68 8.01 3.85 4.27 4.57 7.29 20 49 34 -8.51 3.95
Net Income / (Loss) Discontinued Operations
- - - - - - - - -1.19 -3.94 -3.95
Depreciation Expense
1.22 1.45 1.62 2.05 2.18 2.42 2.30 3.43 4.60 5.92 6.12
Amortization Expense
- - 0.00 0.00 -0.07 -0.06 -0.01 -0.04 -3.51 -4.41 -1.78
Non-Cash Adjustments To Reconcile Net Income
1.10 1.42 3.00 1.99 1.94 0.78 1.49 2.34 3.58 4.39 1.95
Changes in Operating Assets and Liabilities, net
-0.15 0.67 -2.17 -3.76 6.12 -3.77 -13 -53 -14 20 12
Net Cash From Investing Activities
-5.74 -1.64 -12 -13 -13 -0.04 -14 -8.20 -111 -5.27 -7.05
Net Cash From Continuing Investing Activities
-5.74 -1.64 -12 -13 -13 -0.04 -14 -8.20 -111 -5.27 -7.05
Purchase of Property, Plant & Equipment
-4.52 -1.55 -2.02 -1.19 -2.51 -1.81 -2.05 -9.15 -7.44 -7.99 -4.74
Purchase of Investments
-10 -8.14 -18 -7.28 -20 -34 -25 -0.25 -211 -159 -119
Sale of Property, Plant & Equipment
0.08 0.00 0.01 0.08 - - - - 0.00 0.05 0.90
Sale and/or Maturity of Investments
9.09 8.12 8.11 6.13 9.86 36 13 17 107 162 116
Net Cash From Financing Activities
-1.22 0.03 -4.24 -1.93 -0.24 -0.25 -0.54 9.40 113 -33 -17
Net Cash From Continuing Financing Activities
-1.22 0.03 -4.24 -1.93 -0.24 -0.25 -0.54 9.40 113 -33 -17
Repayment of Debt
- - - - - 0.00 0.00 0.00 -17 0.00 0.00
Repurchase of Common Equity
-0.85 -0.33 -3.65 -1.76 0.00 -0.43 - 0.00 0.00 -33 -17
Issuance of Common Equity
0.21 0.25 0.33 0.30 0.31 0.35 0.38 0.54 132 0.59 0.60
Other Financing Activities, net
-0.59 0.11 -0.92 -0.47 -0.55 -0.17 -0.92 -7.85 -1.71 -0.50 -1.18
Other Net Changes in Cash
- - - - - - - -0.02 -5.53 -0.79 4.10
Cash Interest Paid
- - - - - 0.00 0.00 0.12 0.17 0.00 0.00
Cash Income Taxes Paid
0.05 1.13 1.47 0.72 1.68 1.44 5.51 14 13 0.16 1.67

Quarterly Cash Flow Statements for Clearfield

This table details how cash moves in and out of Clearfield's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
6.44 -3.34 -19 9.81 -9.46 14 -1.61 5.02 -16 -7.66 -4.48
Net Cash From Operating Activities
4.94 11 -3.23 3.87 14 7.15 5.30 7.92 3.71 -1.44 -1.07
Net Cash From Continuing Operating Activities
4.94 11 -3.23 3.87 14 8.04 4.41 7.92 8.44 -1.44 -1.07
Net Income / (Loss) Continuing Operations
2.70 -5.27 -5.91 -0.45 -0.83 -0.36 2.55 1.61 2.92 -0.28 -0.53
Consolidated Net Income / (Loss)
2.70 -5.27 -5.91 -0.45 -0.83 -1.91 1.33 1.61 - -0.61 -0.53
Depreciation Expense
1.64 1.65 1.88 1.91 1.93 1.51 1.55 2.06 0.36 1.62 1.58
Amortization Expense
-1.08 -1.16 -1.04 -1.11 -1.10 -0.77 -0.44 -0.35 -0.22 -0.12 -0.15
Non-Cash Adjustments To Reconcile Net Income
1.07 1.27 1.06 1.15 1.20 1.05 1.17 1.32 -1.80 1.27 1.32
Changes in Operating Assets and Liabilities, net
0.61 14 0.78 2.36 13 6.60 -0.42 3.29 2.45 -3.93 -3.28
Net Cash From Investing Activities
0.13 0.91 0.25 11 -19 13 -0.52 0.84 -19 -0.29 3.93
Net Cash From Continuing Investing Activities
0.13 0.91 0.25 11 -19 14 -0.84 0.84 -19 -0.29 3.93
Purchase of Property, Plant & Equipment
-1.86 -2.41 -1.98 -1.22 -3.96 -1.75 -1.32 -0.50 0.48 -0.99 -1.02
Purchase of Investments
- -48 - -76 -35 -39 -20 -19 -40 -20 -32
Sale and/or Maturity of Investments
1.98 51 2.23 89 20 54 21 21 20 22 37
Net Cash From Financing Activities
1.32 -15 -16 -5.22 -3.87 -6.39 -4.83 -3.61 -4.88 -6.09 -7.33
Net Cash From Continuing Financing Activities
1.32 -15 -16 -5.22 -3.87 -6.47 -4.76 -3.61 -4.88 -6.09 -7.33
Repurchase of Common Equity
- -12 -16 -5.56 - -6.28 -4.74 -5.65 0.01 -5.28 -7.32
Other Financing Activities, net
1.32 -0.24 -0.01 - -3.87 -0.49 -0.02 -0.12 -0.56 -1.05 -0.01
Cash Income Taxes Paid
0.38 0.06 0.10 0.01 -0.01 0.41 -0.00 0.83 0.43 -0.01 -0.01

Annual Balance Sheets for Clearfield

This table presents Clearfield's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Total Assets
58 71 69 74 82 95 126 229 356 315 306
Total Current Assets
41 51 41 41 43 53 72 160 296 230 198
Cash & Equivalents
18 28 19 8.55 10 16 13 17 38 14 21
Short-Term Investments
7.93 5.53 5.94 8.93 14 11 10 5.80 130 115 84
Accounts Receivable
6.01 8.00 7.24 13 9.12 10 19 54 28 14 18
Inventories, net
7.18 8.37 8.45 10 9.01 14 28 82 98 56 42
Other Current Assets
0.42 1.20 0.98 0.74 0.77 0.59 0.95 1.76 1.70 11 11
Other Current Nonoperating Assets
- - - - - - - - - 20 21
Plant, Property, & Equipment, net
5.69 5.78 5.43 4.74 5.41 4.95 5.00 18 22 16 9.68
Total Noncurrent Assets
11 14 23 28 34 38 49 51 38 70 98
Long-Term Investments
8.29 11 20 18 24 25 37 23 6.34 25 60
Goodwill
2.57 2.57 2.57 4.71 4.71 4.71 4.71 6.40 6.53 4.71 4.71
Intangible Assets
- - 0.28 5.48 5.15 4.99 4.70 6.38 6.09 4.67 9.35
Noncurrent Deferred & Refundable Income Taxes
- - - - 0.00 0.18 0.37 1.41 3.04 6.14 10
Other Noncurrent Operating Assets
0.32 0.43 0.25 0.23 0.21 2.81 2.72 14 16 12 9.03
Other Noncurrent Nonoperating Assets
- - - - - - - - - 18 4.83
Total Liabilities & Shareholders' Equity
58 71 69 74 82 95 126 229 356 315 306
Total Liabilities
6.35 8.00 4.97 5.35 6.96 13 22 82 40 40 50
Total Current Liabilities
5.04 7.35 4.24 4.98 6.61 10 20 52 29 24 37
Accounts Payable
2.36 2.57 1.74 2.36 3.17 3.69 9.22 24 8.89 2.78 7.03
Accrued Expenses
2.68 4.77 2.50 2.62 3.43 1.20 1.61 6.18 2.40 2.26 2.20
Current Employee Benefit Liabilities
- - - - - 4.86 8.73 14 5.57 4.71 6.60
Other Current Liabilities
- - - - 0.00 0.67 0.92 7.78 10 2.53 2.82
Other Current Nonoperating Liabilities
- - - - - - - - - 12 18
Total Noncurrent Liabilities
1.31 0.66 0.73 0.37 0.35 2.13 1.62 30 11 15 13
Other Noncurrent Operating Liabilities
- - - - 0.00 2.13 1.62 10 11 8.76 5.93
Other Noncurrent Nonoperating Liabilities
- - - - - - - - - 6.40 7.47
Total Equity & Noncontrolling Interests
51 63 65 69 75 83 104 148 315 276 256
Total Preferred & Common Equity
51 63 65 69 75 83 104 148 315 276 256
Preferred Stock
0.00 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
51 63 65 69 75 83 104 148 315 276 256
Common Stock
56 57 56 56 57 58 58 55 188 160 148
Retained Earnings
-4.75 5.13 8.98 13 18 25 45 95 127 115 107
Accumulated Other Comprehensive Income / (Loss)
- - - - - - 0.00 -1.90 -0.54 1.08 1.73

Quarterly Balance Sheets for Clearfield

This table presents Clearfield's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 6/30/2022 3/31/2023 6/30/2023 12/31/2023 3/31/2024 6/30/2024 12/31/2024 3/31/2025 6/30/2025 12/31/2025 3/31/2026
Total Assets
178 357 361 336 315 318 303 311 315 268 264
Total Current Assets
120 301 303 277 257 236 198 206 213 166 163
Cash & Equivalents
14 137 31 34 16 26 30 29 34 14 9.40
Short-Term Investments
3.89 20 131 128 127 98 83 83 83 83 82
Accounts Receivable
32 39 32 17 22 28 14 24 27 15 21
Inventories, net
69 101 105 95 84 75 59 56 54 40 37
Other Current Assets
1.05 3.66 4.08 1.81 8.64 9.88 12 14 15 14 14
Other Current Nonoperating Assets
- - - - - - - - - 0.00 0.00
Plant, Property, & Equipment, net
9.57 21 21 23 22 21 24 25 20 9.48 9.45
Total Noncurrent Assets
48 35 37 36 36 60 82 79 82 93 91
Long-Term Investments
25 8.53 6.56 6.51 6.52 24 42 41 40 60 56
Goodwill
4.71 6.59 6.58 6.62 6.57 6.55 6.49 6.57 6.74 4.71 4.71
Intangible Assets
4.69 6.46 6.34 5.98 6.22 6.40 6.10 5.87 11 8.93 8.40
Noncurrent Deferred & Refundable Income Taxes
0.65 0.96 1.00 2.75 2.84 5.51 6.62 6.83 6.03 11 11
Other Noncurrent Operating Assets
13 13 16 14 13 18 20 19 19 8.29 11
Other Noncurrent Nonoperating Assets
- - - - - - - - - 0.00 0.00
Total Liabilities & Shareholders' Equity
178 357 361 336 315 318 303 311 315 268 264
Total Liabilities
41 52 49 36 36 44 36 45 50 18 21
Total Current Liabilities
31 40 37 25 26 28 19 30 36 13 13
Accounts Payable
16 17 12 7.37 5.91 9.05 4.33 8.68 8.69 3.85 3.68
Accrued Expenses
2.76 5.05 3.34 2.75 2.74 3.03 2.56 3.46 4.70 2.27 1.11
Current Employee Benefit Liabilities
8.92 6.32 7.32 5.28 5.87 7.15 5.40 7.05 8.24 4.20 5.02
Other Current Liabilities
2.77 12 12 7.34 9.69 8.94 6.44 9.14 12 2.89 2.89
Other Current Nonoperating Liabilities
- - - - - - - - - 0.00 0.00
Total Noncurrent Liabilities
10 12 12 11 9.82 15 17 14 14 5.19 8.05
Other Noncurrent Operating Liabilities
10 8.94 12 9.97 9.10 13 15 14 14 5.19 8.05
Other Noncurrent Nonoperating Liabilities
- - - - - - - - - 0.00 0.00
Total Equity & Noncontrolling Interests
137 305 312 300 279 275 267 266 264 250 243
Total Preferred & Common Equity
137 305 312 300 279 275 267 266 264 250 243
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
137 305 312 300 279 275 267 266 264 250 243
Common Stock
60 186 188 177 163 159 154 151 147 143 137
Retained Earnings
78 119 125 122 116 116 113 114 116 106 106
Accumulated Other Comprehensive Income / (Loss)
-0.96 -0.23 -0.27 0.48 0.13 0.02 -0.02 0.59 1.72 0.16 -0.14

Annual Metrics And Ratios for Clearfield

This table displays calculated financial ratios and metrics derived from Clearfield's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
DEI Shares Outstanding
13,720,377.00 14,094,219.00 13,934,910.00 13,660,147.00 13,651,869.00 13,647,005.00 13,742,545.00 - - - 13,806,049.00
DEI Adjusted Shares Outstanding
13,720,377.00 14,094,219.00 13,934,910.00 13,660,147.00 13,651,869.00 13,647,005.00 13,742,545.00 - - - 13,806,049.00
DEI Earnings Per Adjusted Shares Outstanding
0.34 0.57 0.28 0.31 0.33 0.53 1.48 - - - 0.17
Growth Metrics
- - - - - - - - - - -
Revenue Growth
3.93% 24.81% -1.78% 5.01% 9.51% 9.46% 51.23% 92.45% -0.80% -37.96% 19.56%
EBITDA Growth
-10.31% 47.34% -43.08% 2.66% 2.48% 47.25% 156.27% 144.11% -40.73% -150.76% 136.48%
EBIT Growth
-17.22% 52.19% -50.50% -4.54% 2.31% 61.60% 200.98% 152.90% -41.57% -162.28% 111.01%
NOPAT Growth
-14.14% 71.20% -53.67% 7.16% 1.94% 67.09% 198.44% 147.59% -40.93% -155.76% 111.45%
Net Income Growth
-13.82% 71.15% -51.98% 11.09% 6.82% 59.72% 178.72% 142.84% -34.09% -138.28% 35.36%
EPS Growth
-15.00% 73.53% -52.54% 14.29% 6.25% 55.88% 177.36% 141.50% -38.87% -139.17% 31.76%
Operating Cash Flow Growth
-40.60% 68.70% -45.48% -27.79% 223.97% -54.82% 63.81% -79.29% 715.94% 20.62% 22.83%
Free Cash Flow Firm Growth
-86.60% 427.05% -72.89% -622.63% 207.87% -64.72% 103.91% -494.71% 126.01% -44.87% -45.01%
Invested Capital Growth
24.75% 7.98% 10.28% 65.17% -17.94% 11.50% 41.67% 179.43% 17.98% -14.23% -12.75%
Revenue Q/Q Growth
2.46% 7.54% -3.44% 5.51% 1.79% 3.73% 14.59% 80.78% -30.26% -1.72% -16.28%
EBITDA Q/Q Growth
6.24% 10.55% -18.69% 18.57% -4.37% 17.02% 25.88% 25.11% -34.72% -28.32% 3,448.19%
EBIT Q/Q Growth
5.19% 11.73% -23.47% 25.49% -6.65% 21.82% 29.09% 25.30% -35.51% -25.58% 140.49%
NOPAT Q/Q Growth
7.38% 19.41% -28.11% 18.47% -2.20% 22.17% 28.37% 24.99% -35.05% -25.58% 263.46%
Net Income Q/Q Growth
7.38% 19.36% -26.82% 17.01% 0.14% 18.95% 27.44% 24.04% -30.53% -39.45% -4,125.00%
EPS Q/Q Growth
6.25% 20.41% -28.21% 18.52% 0.00% 17.78% 26.72% 24.13% -32.61% -37.10% -5,900.00%
Operating Cash Flow Q/Q Growth
65.79% 22.44% -11.86% -43.69% 60.87% -19.45% -11.59% 134.72% -22.49% 48.22% -30.06%
Free Cash Flow Firm Q/Q Growth
189.29% 23.47% -13.71% -57.59% 88.23% -12.94% -21.19% -70.86% 207.49% 7.67% -20.15%
Invested Capital Q/Q Growth
-2.70% -2.29% -7.24% 7.80% -7.92% -1.99% 15.20% 29.20% -1.80% -4.83% -18.10%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
41.22% 43.66% 40.93% 39.92% 38.44% 40.74% 43.46% 41.70% 31.74% 17.33% 33.66%
EBITDA Margin
13.71% 16.18% 9.38% 9.17% 8.58% 11.54% 19.56% 24.81% 14.82% -12.13% 4.30%
Operating Margin
11.69% 14.25% 7.18% 6.53% 6.10% 9.01% 17.93% 23.56% 13.88% -13.93% 1.41%
EBIT Margin
11.69% 14.25% 7.18% 6.53% 6.10% 9.01% 17.93% 23.56% 13.88% -13.93% 1.41%
Profit (Net Income) Margin
7.76% 10.64% 5.20% 5.50% 5.37% 7.84% 14.44% 18.22% 12.11% -7.47% -5.36%
Tax Burden Percent
65.42% 73.59% 68.89% 77.33% 77.05% 79.66% 78.99% 77.33% 78.18% 76.61% -92.88%
Interest Burden Percent
101.50% 101.47% 105.16% 109.01% 114.23% 109.20% 101.98% 100.03% 111.60% 70.00% 409.21%
Effective Tax Rate
34.58% 26.41% 31.11% 22.67% 22.95% 20.34% 21.01% 22.67% 21.82% 0.00% 27.20%
Return on Invested Capital (ROIC)
30.13% 44.69% 18.97% 14.61% 13.14% 23.03% 53.94% 60.05% 22.10% -12.25% 1.60%
ROIC Less NNEP Spread (ROIC-NNEP)
29.93% 44.39% 18.54% 13.73% 11.77% 21.80% 53.24% 60.02% 18.70% -14.59% 7.25%
Return on Net Nonoperating Assets (RNNOA)
-20.58% -30.62% -12.91% -8.21% -6.79% -13.78% -32.16% -20.78% -8.03% 8.04% -4.63%
Return on Equity (ROE)
9.55% 14.07% 6.05% 6.41% 6.35% 9.25% 21.79% 39.27% 14.06% -4.21% -3.03%
Cash Return on Invested Capital (CROIC)
8.11% 37.01% 9.19% -34.54% 32.85% 12.16% 19.46% -34.53% 5.59% 3.07% 15.22%
Operating Return on Assets (OROA)
12.88% 16.74% 7.58% 7.06% 6.65% 9.46% 22.81% 35.95% 12.76% -6.92% 0.68%
Return on Assets (ROA)
8.55% 12.50% 5.49% 5.95% 5.85% 8.23% 18.38% 27.81% 11.13% -3.71% -2.59%
Return on Common Equity (ROCE)
9.55% 14.07% 6.05% 6.41% 6.35% 9.25% 21.79% 39.27% 14.06% -4.21% -3.03%
Return on Equity Simple (ROE_SIMPLE)
9.13% 12.80% 5.96% 6.21% 6.09% 8.81% 19.58% 33.45% 10.32% -4.52% 0.00%
Net Operating Profit after Tax (NOPAT)
4.61 7.90 3.66 3.92 4.00 6.68 20 49 29 -16 1.54
NOPAT Margin
7.65% 10.49% 4.95% 5.05% 4.70% 7.18% 14.16% 18.22% 10.85% -9.75% 1.03%
Net Nonoperating Expense Percent (NNEP)
0.21% 0.30% 0.43% 0.89% 1.37% 1.23% 0.70% 0.03% 3.40% 2.34% -5.65%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - - 0.60%
Cost of Revenue to Revenue
58.78% 56.34% 59.07% 60.08% 61.56% 59.26% 56.54% 58.30% 68.26% 82.67% 66.34%
SG&A Expenses to Revenue
29.53% 29.41% 33.74% 33.39% 32.34% 31.73% 25.54% 18.14% 17.86% 31.26% 32.25%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
29.53% 29.41% 33.74% 33.39% 32.34% 31.73% 25.54% 18.14% 17.86% 31.26% 32.25%
Earnings before Interest and Taxes (EBIT)
7.05 11 5.31 5.07 5.19 8.38 25 64 37 -23 2.12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
8.27 12 6.93 7.12 7.29 11 28 67 40 -20 6.46
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.59 4.23 2.94 2.67 2.16 3.33 5.84 9.77 1.39 2.01 1.85
Price to Tangible Book Value (P/TBV)
3.78 4.41 3.07 3.13 2.49 3.77 6.43 10.69 1.45 2.11 1.96
Price to Revenue (P/Rev)
3.05 3.52 2.56 2.37 1.90 2.96 4.31 5.32 1.63 3.33 3.16
Price to Earnings (P/E)
39.36 33.07 49.25 42.98 35.43 37.74 29.85 29.21 13.44 0.00 200.87
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
2.54% 3.02% 2.03% 2.33% 2.82% 2.65% 3.35% 3.42% 7.44% 0.00% 0.50%
Enterprise Value to Invested Capital (EV/IC)
8.83 12.03 7.18 4.44 4.17 7.30 12.61 11.69 1.86 3.28 3.45
Enterprise Value to Revenue (EV/Rev)
2.49 2.93 1.96 1.91 1.34 2.40 3.88 5.22 0.99 2.41 2.06
Enterprise Value to EBITDA (EV/EBITDA)
18.14 18.12 20.94 20.83 15.66 20.77 19.84 21.06 6.65 0.00 47.80
Enterprise Value to EBIT (EV/EBIT)
21.27 20.57 27.34 29.24 22.02 26.61 21.65 22.18 7.11 0.00 145.82
Enterprise Value to NOPAT (EV/NOPAT)
32.51 27.95 39.69 37.82 28.59 33.40 27.40 28.68 9.09 0.00 200.29
Enterprise Value to Operating Cash Flow (EV/OCF)
21.90 19.11 23.06 32.61 7.76 33.52 50.10 626.73 14.39 18.06 14.15
Enterprise Value to Free Cash Flow (EV/FCFF)
120.86 33.75 81.91 0.00 11.43 63.27 75.97 0.00 35.91 98.64 21.09
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.13 0.01 0.01 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.13 0.00 0.01 0.00
Financial Leverage
-0.69 -0.69 -0.70 -0.60 -0.58 -0.63 -0.60 -0.35 -0.43 -0.55 -0.64
Leverage Ratio
1.12 1.13 1.10 1.08 1.09 1.12 1.19 1.41 1.26 1.14 1.17
Compound Leverage Factor
1.13 1.14 1.16 1.17 1.24 1.23 1.21 1.41 1.41 0.79 4.78
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 11.23% 0.67% 0.80% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.67% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 11.23% 0.00% 0.80% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 88.77% 99.33% 99.20% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.28 0.05 -0.11 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.39 -4.33 7.58 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.28 0.00 -0.11 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.38 0.07 -0.14 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.54 -5.91 9.43 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.38 0.00 -0.14 0.00
Altman Z-Score
19.49 22.28 25.02 22.70 16.03 15.33 19.25 13.86 9.01 10.00 7.33
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
8.09 6.96 9.70 8.25 6.43 5.04 3.49 3.10 10.21 9.43 5.42
Quick Ratio
6.35 5.66 7.47 6.08 4.95 3.60 2.10 1.47 6.78 6.25 3.39
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1.24 6.54 1.77 -9.27 9.99 3.53 7.19 -28 7.38 4.07 15
Operating Cash Flow to CapEx
154.28% 745.63% 312.33% 410.87% 586.57% 368.55% 532.89% 24.68% 219.75% 232.29% 568.41%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.10 1.17 1.06 1.08 1.09 1.05 1.27 1.53 0.92 0.50 0.48
Accounts Receivable Turnover
10.93 10.75 9.71 7.74 7.75 9.49 9.40 7.41 6.55 6.71 9.43
Inventory Turnover
5.64 5.45 5.19 5.04 5.49 4.71 3.80 2.88 2.04 1.67 2.03
Fixed Asset Turnover
14.80 13.13 13.19 15.26 16.74 17.96 28.29 23.32 13.52 7.33 11.75
Accounts Payable Turnover
15.89 17.20 20.26 22.74 18.91 16.07 12.33 9.48 11.11 17.66 20.30
Days Sales Outstanding (DSO)
33.40 33.96 37.60 47.14 47.09 38.46 38.81 49.28 55.76 54.41 38.70
Days Inventory Outstanding (DIO)
64.72 66.93 70.30 72.38 66.46 77.49 96.17 126.80 179.34 218.26 179.81
Days Payable Outstanding (DPO)
22.97 21.22 18.02 16.05 19.30 22.71 29.59 38.52 32.84 20.67 17.98
Cash Conversion Cycle (CCC)
75.14 79.67 89.88 103.47 94.25 93.25 105.38 137.56 202.25 252.00 200.53
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
17 18 20 33 27 31 43 121 143 122 90
Invested Capital Turnover
3.94 4.26 3.83 2.89 2.80 3.21 3.81 3.30 2.04 1.26 1.56
Increase / (Decrease) in Invested Capital
3.37 1.36 1.89 13 -6.00 3.15 13 78 22 -20 -13
Enterprise Value (EV)
150 221 145 148 114 223 546 1,415 265 401 309
Market Capitalization
184 265 190 184 162 275 607 1,442 437 555 475
Book Value per Share
$3.74 $4.44 $4.63 $5.04 $5.49 $6.06 $7.55 $10.71 $20.65 $19.37 $18.55
Tangible Book Value per Share
$3.55 $4.26 $4.43 $4.30 $4.77 $5.35 $6.87 $9.78 $19.82 $18.46 $17.54
Total Capital
51 63 65 69 75 83 104 166 317 278 256
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 19 2.11 2.23 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 19 0.00 2.23 0.00
Net Debt
-34 -44 -44 -35 -48 -52 -61 -27 -172 -153 -166
Capital Expenditures (CapEx)
4.44 1.55 2.02 1.11 2.51 1.81 2.05 9.15 8.38 9.57 3.84
Debt-free, Cash-free Net Working Capital (DFCFNWC)
9.72 10 12 19 12 15 27 86 101 74 56
Debt-free Net Working Capital (DFNWC)
36 44 37 36 36 42 51 108 269 205 162
Net Working Capital (NWC)
36 44 37 36 36 42 51 108 267 205 162
Net Nonoperating Expense (NNE)
-0.07 -0.12 -0.19 -0.35 -0.57 -0.61 -0.39 -0.01 -3.38 -3.80 9.59
Net Nonoperating Obligations (NNO)
-34 -44 -44 -35 -48 -52 -61 -27 -172 -153 -167
Total Depreciation and Amortization (D&A)
1.22 1.45 1.62 2.05 2.11 2.36 2.30 3.38 2.54 3.01 4.34
Debt-free, Cash-free Net Working Capital to Revenue
16.11% 13.58% 16.81% 24.00% 14.46% 16.20% 19.50% 31.74% 37.68% 44.54% 37.24%
Debt-free Net Working Capital to Revenue
59.21% 58.13% 49.90% 46.50% 42.22% 45.24% 36.26% 40.03% 100.24% 123.12% 107.83%
Net Working Capital to Revenue
59.21% 58.13% 49.90% 46.50% 42.22% 45.24% 36.26% 40.03% 99.45% 123.12% 107.83%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.35 $0.60 $0.28 $0.32 $0.34 $0.53 $1.48 $3.58 $2.17 ($0.85) ($0.58)
Adjusted Weighted Average Basic Shares Outstanding
13.22M 13.37M 13.53M 13.43M 13.44M 13.64M 13.72M 13.77M 14.98M 14.58M 13.99M
Adjusted Diluted Earnings per Share
$0.34 $0.59 $0.28 $0.32 $0.34 $0.53 $1.47 $3.55 $2.17 ($0.85) ($0.58)
Adjusted Weighted Average Diluted Shares Outstanding
13.59M 13.66M 13.66M 13.45M 13.45M 13.64M 13.78M 13.91M 15.01M 14.58M 13.99M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
13.70M 14.13M 13.81M 13.65M 13.64M 13.65M 13.73M 13.82M 15.25M 14.29M 13.84M
Normalized Net Operating Profit after Tax (NOPAT)
4.61 7.90 3.66 3.92 4.00 6.68 20 49 29 -16 1.54
Normalized NOPAT Margin
7.65% 10.49% 4.95% 5.05% 4.70% 7.18% 14.16% 18.22% 10.85% -9.75% 1.03%
Pre Tax Income Margin
11.86% 14.46% 7.55% 7.12% 6.97% 9.84% 18.28% 23.57% 15.49% -9.75% 5.77%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
18.14% 4.17% 94.79% 41.18% 0.00% 5.88% 0.00% 0.00% 0.00% -268.00% -206.87%

Quarterly Metrics And Ratios for Clearfield

This table displays calculated financial ratios and metrics derived from Clearfield's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - 14,131,537.00 13,830,950.00 13,806,049.00 13,839,096.00 13,685,411.00
DEI Adjusted Shares Outstanding
- - - - - - 14,131,537.00 13,830,950.00 13,806,049.00 13,839,096.00 13,685,411.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - 0.09 0.12 0.10 -0.04 -0.04
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-70.12% -60.17% -48.60% -20.38% -5.86% 3.64% 10.05% 2.27% 212.10% 15.63% -15.34%
EBITDA Growth
-90.29% -140.32% -170.62% -125.41% -195.96% 62.14% 131.55% 312.28% 1,314.56% 74.90% -123.16%
EBIT Growth
-92.28% -145.62% -180.80% -141.00% -275.48% 51.29% 117.27% 164.87% 344.72% 10.85% -223.01%
NOPAT Growth
-91.75% -140.21% -172.79% -138.83% -248.72% 51.29% 119.22% 149.98% 284.20% 10.85% -210.50%
Net Income Growth
-84.13% -136.96% -157.03% -108.57% -130.68% 63.82% 122.45% 459.28% -997.58% 67.79% -139.79%
EPS Growth
-86.07% -135.00% -159.70% -112.12% -135.29% 62.86% 122.50% 375.00% -983.33% 69.23% -144.44%
Operating Cash Flow Growth
-57.19% 879.15% -135.74% 15.78% 178.35% -33.80% 192.88% 96.14% -57.04% -120.14% -120.23%
Free Cash Flow Firm Growth
66.38% 104.62% -254.71% 131.75% 189.51% 372.02% 113.35% 32.94% -59.14% 20.14% -5.36%
Invested Capital Growth
17.98% -6.35% 0.00% -11.50% -14.23% -13.83% -13.05% -14.98% -12.75% -18.90% -16.55%
Revenue Q/Q Growth
-18.93% -31.11% 7.83% 32.19% -4.14% -24.15% 36.78% 5.80% -64.76% 95.26% 0.15%
EBITDA Q/Q Growth
-61.56% -436.89% -16.69% 83.09% -45.18% -32.91% 315.09% 88.17% 39.82% -107.29% -98.47%
EBIT Q/Q Growth
-69.48% -575.36% -19.35% 76.33% -30.66% -31.96% 182.21% 470.99% 189.84% -142.07% -13.43%
NOPAT Q/Q Growth
-65.89% -502.86% -19.35% 76.33% -30.66% -31.96% 191.51% 313.51% 355.10% -134.78% -13.43%
Net Income Q/Q Growth
-48.33% -295.40% -12.21% 92.44% -85.01% -130.47% 169.62% 21.02% -665.19% 93.24% 14.01%
EPS Q/Q Growth
-48.48% -305.88% -14.29% 90.00% -50.00% -116.67% 169.23% 22.22% -690.91% 93.85% 0.00%
Operating Cash Flow Q/Q Growth
47.99% 118.49% -141.27% 219.72% 255.81% -48.03% -25.87% 159.78% -53.13% -138.80% 25.56%
Free Cash Flow Firm Q/Q Growth
57.23% 116.25% -4,296.33% 110.89% 20.56% -14.32% 9.26% 15.35% -16.50% 21.48% -13.93%
Invested Capital Q/Q Growth
-1.80% -6.90% -0.78% -2.44% -4.83% -6.46% 0.12% -4.60% -18.10% 3.68% 3.02%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
24.14% 13.72% 7.67% 21.91% 22.81% 23.06% 34.37% 30.53% 73.51% 33.16% 32.45%
EBITDA Margin
4.58% -22.41% -24.11% -3.08% -4.67% -8.19% 6.88% 6.41% 25.42% -0.95% -1.88%
Operating Margin
3.46% -23.84% -26.39% -4.73% -6.44% -11.21% 4.14% 3.00% 24.65% -5.31% -6.02%
EBIT Margin
3.46% -23.84% -26.39% -4.73% -6.44% -11.21% 4.14% 3.00% 24.65% -5.31% -6.02%
Profit (Net Income) Margin
5.43% -15.39% -16.01% -0.92% -1.77% -5.37% 3.27% 3.22% -51.61% -1.79% -1.54%
Tax Burden Percent
82.60% 84.71% 73.94% 61.74% 62.70% 81.73% 40.58% 53.93% -145.49% 220.86% 75.00%
Interest Burden Percent
190.10% 76.19% 82.07% 31.40% 43.78% 58.65% 194.41% 199.06% 143.89% 15.24% 34.03%
Effective Tax Rate
17.40% 0.00% 0.00% 0.00% 0.00% 0.00% 22.08% 46.07% 15.32% 0.00% 0.00%
Return on Invested Capital (ROIC)
5.81% -26.35% -51.00% -4.09% -5.67% -10.65% 3.26% 2.43% 32.59% -5.55% -5.95%
ROIC Less NNEP Spread (ROIC-NNEP)
4.53% -26.62% -52.23% -4.84% -6.45% -11.19% 3.25% 1.90% 40.10% -5.97% -6.56%
Return on Net Nonoperating Assets (RNNOA)
-1.95% 14.53% 27.55% 2.58% 3.56% 6.31% -1.78% -1.06% -25.60% 3.58% 3.85%
Return on Equity (ROE)
3.87% -11.82% -23.45% -1.52% -2.11% -4.33% 1.48% 1.37% 6.99% -1.97% -2.10%
Cash Return on Invested Capital (CROIC)
5.59% 12.66% -211.21% 2.76% 3.07% 4.09% 12.73% 15.40% 15.22% 22.53% 17.10%
Operating Return on Assets (OROA)
3.18% -14.93% -15.24% -2.36% -3.20% -5.89% 1.65% 1.70% 11.91% -2.88% -3.11%
Return on Assets (ROA)
4.99% -9.64% -9.25% -0.46% -0.88% -2.82% 1.30% 1.82% -24.94% -0.97% -0.79%
Return on Common Equity (ROCE)
3.87% -11.82% -23.45% -1.52% -2.11% -4.33% 1.48% 1.37% 6.99% -1.97% -2.10%
Return on Equity Simple (ROE_SIMPLE)
0.00% 4.34% -1.17% -3.25% 0.00% -3.40% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
1.42 -5.71 -6.82 -1.61 -2.11 -2.78 1.31 0.81 3.67 -1.28 -1.45
NOPAT Margin
2.85% -16.69% -18.47% -3.31% -4.51% -7.85% 3.23% 1.62% 20.88% -3.72% -4.21%
Net Nonoperating Expense Percent (NNEP)
1.29% 0.27% 1.23% 0.75% 0.79% 0.55% 0.01% 0.53% -7.51% 0.43% 0.62%
Return On Investment Capital (ROIC_SIMPLE)
- -1.89% - - - -1.03% 0.49% 0.30% 1.43% -0.51% -0.60%
Cost of Revenue to Revenue
75.86% 86.28% 92.33% 78.09% 77.19% 76.94% 65.63% 69.47% 26.49% 66.84% 67.55%
SG&A Expenses to Revenue
20.68% 37.57% 34.06% 26.64% 29.25% 34.27% 30.23% 27.53% 48.86% 38.47% 38.47%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
20.68% 37.57% 34.06% 26.64% 29.25% 34.27% 30.23% 27.53% 48.86% 38.47% 38.47%
Earnings before Interest and Taxes (EBIT)
1.72 -8.16 -9.74 -2.31 -3.01 -3.98 1.68 1.50 4.34 -1.82 -2.07
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2.28 -7.67 -8.90 -1.51 -2.19 -2.90 2.79 3.20 4.47 -0.33 -0.65
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.39 1.48 1.62 2.00 2.01 1.66 1.58 2.27 1.85 1.62 1.49
Price to Tangible Book Value (P/TBV)
1.45 1.54 1.70 2.10 2.11 1.74 1.66 2.43 1.96 1.71 1.58
Price to Revenue (P/Rev)
1.63 2.05 2.49 3.24 3.33 2.64 3.37 3.35 3.16 2.61 2.44
Price to Earnings (P/E)
13.44 34.11 0.00 0.00 0.00 0.00 0.00 3,002.01 200.87 110.37 201.25
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
7.44% 2.93% 0.00% 0.00% 0.00% 0.00% 0.00% 0.03% 0.50% 0.91% 0.50%
Enterprise Value to Invested Capital (EV/IC)
1.86 2.08 2.32 3.13 3.28 2.53 2.34 4.07 3.45 2.65 2.25
Enterprise Value to Revenue (EV/Rev)
0.99 1.28 1.68 2.38 2.41 1.73 2.15 2.48 2.06 1.59 1.45
Enterprise Value to EBITDA (EV/EBITDA)
6.65 21.07 0.00 0.00 0.00 0.00 881.34 0.00 47.80 33.18 53.88
Enterprise Value to EBIT (EV/EBIT)
7.11 24.63 0.00 0.00 0.00 0.00 0.00 0.00 145.82 105.42 0.00
Enterprise Value to NOPAT (EV/NOPAT)
9.09 33.02 0.00 0.00 0.00 0.00 0.00 0.00 200.29 143.43 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
14.39 9.84 21.17 26.88 18.06 15.62 10.70 14.27 14.15 18.64 31.34
Enterprise Value to Free Cash Flow (EV/FCFF)
35.91 15.90 0.00 106.62 98.64 57.26 17.12 24.29 21.09 10.56 11.96
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.43 -0.55 -0.53 -0.53 -0.55 -0.56 -0.55 -0.56 -0.64 -0.60 -0.59
Leverage Ratio
1.26 1.14 1.13 1.16 1.14 1.13 1.15 1.17 1.17 1.10 1.13
Compound Leverage Factor
2.40 0.87 0.93 0.36 0.50 0.66 2.23 2.34 1.68 0.17 0.38
Debt to Total Capital
0.67% 0.73% 0.77% 0.77% 0.80% 0.77% 0.81% 0.88% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.67% 0.73% 0.77% 0.00% 0.00% 0.00% 0.81% 0.88% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.77% 0.80% 0.77% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
99.33% 99.27% 99.23% 99.23% 99.20% 99.23% 99.19% 99.12% 100.00% 100.00% 100.00%
Debt to EBITDA
0.05 0.17 -0.26 -0.14 -0.11 -0.13 7.10 -12.22 0.00 0.00 0.00
Net Debt to EBITDA
-4.33 -12.73 17.69 9.26 7.58 9.89 -495.68 803.31 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 -0.14 -0.11 -0.13 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.07 0.26 -0.29 -0.17 -0.14 -0.16 -1.42 -2.50 0.00 0.00 0.00
Net Debt to NOPAT
-5.91 -19.94 19.92 11.27 9.43 11.47 99.49 164.35 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 -0.17 -0.14 -0.16 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
8.68 9.47 9.39 9.37 10.21 9.17 7.22 8.95 7.36 14.95 12.26
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
10.21 11.09 9.76 8.38 9.43 10.57 6.76 5.93 5.42 12.55 12.84
Quick Ratio
6.78 7.22 6.25 5.38 6.25 6.79 4.47 4.01 3.39 8.43 8.82
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-20 3.31 -139 15 18 16 19 20 17 20 18
Operating Cash Flow to CapEx
266.47% 447.76% -163.38% 317.23% 347.54% 345.58% 400.60% 1,586.77% 0.00% -145.75% -105.20%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.92 0.63 0.58 0.50 0.50 0.53 0.40 0.57 0.48 0.54 0.52
Accounts Receivable Turnover
6.55 7.65 8.32 5.69 6.71 10.69 5.41 6.61 9.43 10.66 6.59
Inventory Turnover
2.04 1.61 1.71 1.55 1.67 1.76 1.20 2.04 2.03 2.04 2.11
Fixed Asset Turnover
13.52 9.87 8.12 7.93 7.33 7.21 5.24 8.70 11.75 9.33 8.58
Accounts Payable Turnover
11.11 13.12 24.27 13.48 17.66 23.19 11.48 14.78 20.30 24.83 15.87
Days Sales Outstanding (DSO)
55.76 47.72 43.89 64.10 54.41 34.15 67.44 55.21 38.70 34.24 55.36
Days Inventory Outstanding (DIO)
179.34 226.22 213.60 235.48 218.26 207.08 305.07 179.13 179.81 178.72 173.03
Days Payable Outstanding (DPO)
32.84 27.83 15.04 27.09 20.67 15.74 31.79 24.70 17.98 14.70 23.00
Cash Conversion Cycle (CCC)
202.25 246.11 242.45 272.50 252.00 225.49 340.71 209.64 200.53 198.26 205.39
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
143 133 132 129 122 115 115 109 90 93 96
Invested Capital Turnover
2.04 1.58 2.76 1.24 1.26 1.36 1.01 1.51 1.56 1.49 1.41
Increase / (Decrease) in Invested Capital
22 -9.02 132 -17 -20 -18 -17 -19 -13 -22 -19
Enterprise Value (EV)
265 277 306 403 401 290 269 445 309 247 215
Market Capitalization
437 444 454 549 555 443 420 600 475 403 362
Book Value per Share
$20.65 $19.73 $18.99 $19.29 $19.37 $18.72 $18.82 $19.12 $18.55 $18.04 $17.74
Tangible Book Value per Share
$19.82 $18.90 $18.12 $18.38 $18.46 $17.84 $17.94 $17.86 $17.54 $17.05 $16.78
Total Capital
317 302 281 277 278 270 268 267 256 250 243
Total Debt
2.11 2.21 2.16 2.14 2.23 2.07 2.17 2.36 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 2.14 2.23 2.07 0.00 0.00 0.00 0.00 0.00
Net Debt
-172 -167 -147 -146 -153 -153 -151 -155 -166 -157 -147
Capital Expenditures (CapEx)
1.86 2.41 1.98 1.22 3.96 2.07 1.32 0.50 -0.48 0.99 1.02
Debt-free, Cash-free Net Working Capital (DFCFNWC)
101 91 90 84 74 66 66 62 56 56 59
Debt-free Net Working Capital (DFNWC)
269 254 233 208 205 179 178 179 162 153 150
Net Working Capital (NWC)
267 252 231 208 205 179 176 177 162 153 150
Net Nonoperating Expense (NNE)
-1.28 -0.45 -0.91 -1.17 -1.28 -0.88 -0.02 -0.80 13 -0.66 -0.92
Net Nonoperating Obligations (NNO)
-172 -167 -147 -146 -153 -153 -151 -155 -167 -157 -147
Total Depreciation and Amortization (D&A)
0.56 0.49 0.84 0.80 0.83 1.07 1.11 1.70 0.13 1.50 1.42
Debt-free, Cash-free Net Working Capital to Revenue
37.68% 41.95% 49.59% 49.65% 44.54% 39.40% 52.86% 34.51% 37.24% 36.24% 39.88%
Debt-free Net Working Capital to Revenue
100.24% 116.99% 128.06% 122.65% 123.12% 106.69% 142.64% 99.88% 107.83% 98.55% 101.19%
Net Working Capital to Revenue
99.45% 115.97% 126.88% 122.65% 123.12% 106.69% 140.90% 98.57% 107.83% 98.55% 101.19%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.16 ($0.35) ($0.40) ($0.04) ($0.06) ($0.13) $0.09 $0.11 ($0.65) ($0.04) ($0.04)
Adjusted Weighted Average Basic Shares Outstanding
14.98M 15.21M 14.63M 14.25M 14.58M 14.21M 14.10M 13.83M 13.99M 13.87M 13.67M
Adjusted Diluted Earnings per Share
$0.17 ($0.35) ($0.40) ($0.04) ($0.06) ($0.13) $0.09 $0.11 ($0.65) ($0.04) ($0.04)
Adjusted Weighted Average Diluted Shares Outstanding
15.01M 15.21M 14.63M 14.25M 14.58M 14.21M 14.10M 13.83M 13.99M 13.87M 13.67M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
15.25M 14.71M 14.23M 14.24M 14.29M 14.13M 13.83M 13.81M 13.84M 13.69M 13.59M
Normalized Net Operating Profit after Tax (NOPAT)
1.42 -5.71 -6.82 -1.61 -2.11 -2.78 1.31 0.81 3.67 -1.28 -1.45
Normalized NOPAT Margin
2.85% -16.69% -18.47% -3.31% -4.51% -7.85% 3.23% 1.62% 20.88% -3.72% -4.21%
Pre Tax Income Margin
6.57% -18.17% -21.66% -1.48% -2.82% -6.57% 8.05% 5.97% 35.48% -0.81% -2.05%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 93.65% 0.00% 0.00% -268.00% -302.11% -894.50% 8,332.50% -206.87% -231.68% -211.71%

Financials Breakdown Chart

Key Financial Trends

Clearfield (NASDAQ: CLFD) has seen a dramatic downturn from its peak operating performance in 2022 to a much more mixed picture in the latest quarter. Revenue has stabilized around the mid-$30 million range in recent quarters, but profitability remains under pressure, and Q2 2026 showed another operating loss and negative operating cash flow despite a strong liquidity position.

  • Strong liquidity remains a major support. As of Q2 2026, Clearfield held $9.4 million in cash and equivalents plus $81.7 million in short-term investments, along with $56.0 million in long-term investments.
  • The balance sheet is still net cash-rich. Total assets were $263.5 million versus only $20.7 million in total liabilities, giving the company significant financial flexibility.
  • Gross margin held up reasonably well in Q2 2026. Revenue was $34.4 million and gross profit was $11.2 million, implying a gross margin of about 32.5%.
  • Interest and investment income continues to cushion losses. Q2 2026 generated $1.4 million in interest and investment income, helping offset operating weakness.
  • Share count has edged lower over time. Weighted average shares in Q2 2026 were down from earlier periods, reflecting ongoing buybacks that can support per-share results when the business improves.
  • Revenue has been fairly flat in the last two quarters. Q1 2026 revenue was $34.3 million versus $34.4 million in Q2 2026, suggesting stabilization but not yet a growth rebound.
  • Operating expenses remain elevated relative to gross profit. In Q2 2026, SG&A was $13.2 million against $11.2 million of gross profit, resulting in an operating loss.
  • The company continues to carry meaningful inventory. Inventory was $36.9 million in Q2 2026, which is lower than prior peaks but still a large working-capital item to monitor.
  • Capital allocation has shifted between buybacks and investment activity. Q2 2026 included $7.3 million of share repurchases and net investment inflows, showing management is still actively managing the capital structure.
  • Q2 2026 was an operating loss quarter. Operating income was a loss of $2.1 million, and net loss was $528,000.
  • Operating cash flow turned negative. Clearfield used $1.1 million in operating cash in Q2 2026, driven by unfavorable changes in operating assets and liabilities.
  • Free cash flow pressure is visible. Even with investment proceeds, the core business is not yet consistently generating positive cash from operations.
  • Profitability is well below last year’s stronger periods. In 2024 and early 2025, Clearfield had several profitable quarters; by Q1 and Q2 2026, it was back to small losses.
  • Long-term performance has been volatile. Revenue and earnings were much stronger in 2022, but the company has since gone through a significant contraction and recovery attempt.

Bottom line: Clearfield’s biggest strength is its balance sheet, not its current earnings power. The company has plenty of liquidity and low leverage, but the core business still needs to prove it can translate stable revenue into consistent operating profit and positive operating cash flow. For retail investors, this makes CLFD more of a turnaround story than a steady compounder right now.

05/28/26 02:04 PM ETAI Generated. May Contain Errors.

Clearfield Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Clearfield's fiscal year ends in September. Their fiscal year 2025 ended on September 30, 2025.

Clearfield's net income appears to be on an upward trend, with a most recent value of -$8.05 million in 2025, falling from $4.68 million in 2015. The previous period was -$12.45 million in 2024. Check out Clearfield's forecast to explore projected trends and price targets.

Clearfield's total operating income in 2025 was $2.12 million, based on the following breakdown:
  • Total Gross Profit: $50.54 million
  • Total Operating Expenses: $48.42 million

Over the last 10 years, Clearfield's total revenue changed from $60.32 million in 2015 to $150.13 million in 2025, a change of 148.9%.

Clearfield's total liabilities were at $50.01 million at the end of 2025, a 26.6% increase from 2024, and a 687.7% increase since 2015.

In the past 10 years, Clearfield's cash and equivalents has ranged from $8.55 million in 2018 to $37.83 million in 2023, and is currently $21.49 million as of their latest financial filing in 2025.

Over the last 10 years, Clearfield's book value per share changed from 3.74 in 2015 to 18.55 in 2025, a change of 396.5%.



Financial statements for NASDAQ:CLFD last updated on 5/27/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners